Avalo Therapeutics, Inc. ($AVTX)
Sullivan Christopher Ryan โ Chief Financial Officer
Shares
138
Price
$13.10
Total Value
$1,807.80
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Sullivan Christopher Ryan |
|---|---|
| Title | Chief Financial Officer |
| Transaction Date | Jun 10, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Jun 12, 2026 |
| Shares Purchased | 138 |
| Price per Share | $13.10 |
| Total Value | $1,807.80 |
| Shares Owned After | 40,773 |
| Derivative | No |
| Accession Number | 0001810417-26-000016 |
| Document | View SEC Filing |